Innoviva to Participate in Upcoming Investor Conferences

BURLINGAME, Calif. --(BUSINESS WIRE)--Aug. 26, 2025-- Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio